Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Alemtuzumab and multiple sclerosis: Is it safe?
Efficient in vivo depletion of CD8(+) T lymphocytes in common marmosets by novel CD8 monoclonal antibody administration.
Presence of aberrant V<formula>_{H}</formula>6 domains in anti-interferon-γ autoantibodies in multiple sclerosis.
MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Functional plasticity of the visual system in multiple sclerosis.
The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.
The effects of exercise training on fitness, mobility, fatigue, and health related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development.
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of disease.
Severe Autoimmune Adverse Events Post Herpes Zoster Vaccine: A Case-Control Study of Adverse Events in a National Database.
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
Biomechanical disorders of foot in multiple sclerosis.
The effects of identification with a support group on the mental health of people with multiple sclerosis.
The effects of clinical interventions on health-related quality of life in multiple sclerosis: a meta-analysis.
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
Neuroradiological evaluation of demyelinating disease.

Pages